Sequent Scientific Limited (NSE:SEQUENT)

Market Cap	45.63B
Revenue (ttm)	15.11B
Net Income (ttm)	116.51M
Shares Out	n/a
EPS (ttm)	0.46
PE Ratio	391.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,275,041
Average Volume	937,943
Open	177.75
Previous Close	176.34
Day's Range	170.64 - 185.95
52-Week Range	92.05 - 240.70
Beta	1.03
RSI	73.28
Earnings Date	May 21, 2025

About Sequent Scientific

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology fo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1985
• Employees: 1,195
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SEQUENT

Financial Performance

In 2023, Sequent Scientific's revenue was 13.70 billion, a decrease of -3.60% compared to the previous year's 14.21 billion. Losses were -358.69 million, -70.40% less than in 2022.